{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:34:38Z","timestamp":1788021278785,"version":"build-2784847793"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,15]]},"DOI":"10.7759\/cureus.20449","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T06:26:46Z","timestamp":1639636006000},"source":"Crossref","is-referenced-by-count":3,"title":["High Rate of Obstetric Complications in Patients With Essential Thrombocythemia"],"prefix":"10.7759","author":[{"given":"Dicle","family":"\u0130skender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seval","family":"Y\u0131lmaz-Ergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munevver","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Tokgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujde Can","family":"Ibanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merih","family":"K\u0131z\u0131l \u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turhan","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fevzi","family":"Altuntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000521","article-title":"Low-risk essential thrombocythemia: a comprehensive review","volume":"5","author":"Robinson AJ","year":"2021","unstructured":"Robinson AJ, Godfrey AL. Low-risk essential thrombocythemia: a comprehensive review. Hemasphere. 2021, 5:e521. 10.1097\/HS9.0000000000000521","journal-title":"Hemasphere"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.813500","article-title":"Epidemiology of myeloproliferative neoplasms in the United States","volume":"55","author":"Mehta J","year":"2014","unstructured":"Mehta J, Wang H, Iqbal SU, Mesa R. Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 2014, 55:595-600. 10.3109\/10428194.2013.813500","journal-title":"Leuk Lymphoma"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106500","article-title":"Esssential thrombocythaemia and pregnancy-a need for prospective study and a consensus on its management","volume":"102","author":"Burbury K","year":"2021","unstructured":"Burbury K, Panigrahi A. Esssential thrombocythaemia and pregnancy-a need for prospective study and a consensus on its management. Leuk Res. 2021, 102:106500. 10.1016\/j.leukres.2021.106500","journal-title":"Leuk Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008859730818","article-title":"Leukemias and lymphomas: time trends in the UK, 1984-93","volume":"10","author":"McNally RJ","year":"1999","unstructured":"McNally RJ, Roman E, Cartwright RA. Leukemias and lymphomas: time trends in the UK, 1984-93. Cancer Causes Control. 1999, 10:35-42. 10.1023\/a:1008859730818","journal-title":"Cancer Causes Control"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp ER","year":"2008","unstructured":"Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008, 6:632-7. 10.1111\/j.1538-7836.2008.02921.x","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01214.x","article-title":"Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies","volume":"82","author":"Gangat N","year":"2009","unstructured":"Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur J Haematol. 2009, 82:350-3. 10.1111\/j.1600-0609.2009.01214.x","journal-title":"Eur J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-071068","article-title":"Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation","volume":"110","author":"Passamonti F","year":"2007","unstructured":"Passamonti F, Randi ML, Rumi E, et al.. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V&gt;F) mutation. Blood. 2007, 110:485-9. 10.1182\/blood-2007-01-071068","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016203","article-title":"Essential thrombocytosis with recurrent spontaneous abortion in the mid trimester: a case report","volume":"98","author":"Yu Y","year":"2019","unstructured":"Yu Y, Zhang X, Shi Q, Wang M, Jing J, Liu Y. Essential thrombocytosis with recurrent spontaneous abortion in the mid trimester: a case report. Medicine (Baltimore). 2019, 98:e16203. 10.1097\/MD.0000000000016203","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1863362","article-title":"What factors determine the pregnancy outcome in patients with essential thrombocythemia?","author":"Kwiatkowski J","year":"2021","unstructured":"Kwiatkowski J, Kuliszkiewicz-Janus M, Potoczek S, Ja\u017awiec B, Wr\u00f3bel T, Ma\u0142ecki R. What factors determine the pregnancy outcome in patients with essential thrombocythemia?. J Matern Fetal Neonatal Med. 2021, 1-5. 10.1080\/14767058.2020.1863362","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","unstructured":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013, 122.1122-31. 10.1097\/01.AOG.0000437382.03963.88","journal-title":"Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn SJ","year":"2016","unstructured":"Gordijn SJ, Beune IM, Thilaganathan B, et al.. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016, 48:333-9. 10.1002\/uog.15884","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/life11070677","article-title":"Liquid biopsy and potential liquid biopsy-based biomarkers in Philadelphia-negative classical myeloproliferative neoplasms: a systematic review","volume":"11","author":"G\u0103man MA","year":"2021","unstructured":"G\u0103man MA, Cozma MA, Dobric\u0103 EC, Cre\u021boiu SM, G\u0103man AM, Diaconu CC. Liquid biopsy and potential liquid biopsy-based biomarkers in Philadelphia-negative classical myeloproliferative neoplasms: a systematic review. Life (Basel). 2021, 11:10.3390\/life11070677","journal-title":"Life (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21504","article-title":"Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry","volume":"84","author":"Melillo L","year":"2009","unstructured":"Melillo L, Tieghi A, Candoni A, et al.. Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry. Am J Hematol. 2009, 84:636-40. 10.1002\/ajh.21504","journal-title":"Am J Hematol"},{"key":"ref15","article-title":"Idiopathic thrombocythemia and pregnancy: report of a case","volume":"65","author":"Kaibara M","year":"1985","unstructured":"Kaibara M, Kobayashi T, Matsumoto S. Idiopathic thrombocythemia and pregnancy: report of a case. Obstet Gynecol. 1985, 65:18S-9S.","journal-title":"Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(88)90507-8","article-title":"Primary thrombocythemia in pregnancy: a report of two cases","volume":"159","author":"Mercer B","year":"1988","unstructured":"Mercer B, Drouin J, Jolly E, d'Anjou G. Primary thrombocythemia in pregnancy: a report of two cases. Am J Obstet Gynecol. 1988, 159:127-8. 10.1016\/0002-9378(88)90507-8","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830250316","article-title":"Essential thrombocythemia associated with recurrent abortions and fetal growth retardation","volume":"25","author":"Falconer J","year":"1987","unstructured":"Falconer J, Pineo G, Blahey W, Bowen T, Docksteader B, Jadusingh I. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation. Am J Hematol. 1987, 25:345-7. 10.1002\/ajh.2830250316","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106459","article-title":"Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia","volume":"98","author":"How J","year":"2020","unstructured":"How J, Leiva O, Bogue T, et al.. Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia. Leuk Res. 2020, 98:106459. 10.1016\/j.leukres.2020.106459","journal-title":"Leuk Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik DL","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, et al.. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017, 50:492-5. 10.1002\/uog.18816","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80339-high-rate-of-obstetric-complications-in-patients-with-essential-thrombocythemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:05Z","timestamp":1707507245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80339-high-rate-of-obstetric-complications-in-patients-with-essential-thrombocythemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.20449","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,15]]}}}